Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma

Author:                

Publisher: Spandidos Publications

E-ISSN: 1792-1082|10|2|778-784

ISSN: 1792-1074

Source: Oncology Letters, Vol.10, Iss.2, 2015-01, pp. : 778-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content